Research programme: anticancer antibiotics - Astellas PharmaAlternative Names: Thioviridamide
Latest Information Update: 05 Feb 2008
At a glance
- Originator Astellas Pharma; University of Tokyo
- Class Cyclic peptides
- Mechanism of Action Apoptosis stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 30 Jun 2006 A clinical study has been added to the Cancer pharmacodynamics section